The Strange Allure of State 'Right-to-Try' Laws

174 JAMA Internal Medicine 1885 (2014)

Posted: 19 Aug 2015

See all articles by Patricia J. Zettler

Patricia J. Zettler

Georgia State University - College of Law

Henry T. Greely

Stanford Law School

Date Written: September 29, 2014

Abstract

State right-to-try laws revive a decades-long debate about balancing early access to unapproved medications for terminally ill patients with requirements for demonstrated safety and effectiveness. Although the legal approach is novel, there are many reasons to believe that the laws are likely to be futile. The laws also raise questions about the roles of the state and federal governments in overseeing drugs and medical devices.

Keywords: FDA, compassionate use, drugs, federalism, health law and policy

Suggested Citation

Zettler, Patricia J. and Greely, Henry (Hank) T., The Strange Allure of State 'Right-to-Try' Laws (September 29, 2014). 174 JAMA Internal Medicine 1885 (2014). Available at SSRN: https://ssrn.com/abstract=2646060

Patricia J. Zettler (Contact Author)

Georgia State University - College of Law ( email )

P.O. Box 4037
Atlanta, GA 30302-4037
United States

Henry (Hank) T. Greely

Stanford Law School ( email )

559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-723-2517 (Phone)
650-725-0253 (Fax)

Register to save articles to
your library

Register

Paper statistics

Abstract Views
210
PlumX Metrics
!

Under construction: SSRN citations while be offline until July when we will launch a brand new and improved citations service, check here for more details.

For more information